| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | -100.0% | — |
| R&D Expense | $4.3M | -20.5% | +34.7% |
| SG&A Expense | $6.0M | +10.0% | -2.5% |
| Operating Income | -$10.0M | +4.6% | -6.8% |
| Interest Expense | $28K | +16.7% | -92.1% |
| Pre-tax Income | -$7.0M | +51.9% | +53.2% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $48.7M | -13.2% | -39.5% |
| Current Assets | $52.4M | -14.7% | -39.6% |
| Total Assets | $53.6M | -14.4% | -39.6% |
| Current Liabilities | $6.0M | -20.4% | -57.7% |
| Total Liabilities | $7.0M | -17.2% | -56.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.3M | — | — |
| Capital Expenditures | $20K | — | — |
| Investing Cash Flow | -$20K | — | — |
| Financing Cash Flow | $288K | — | — |
| Free Cash Flow | -$23.3M | — | — |
| — |
| Net Income | -$7.0M | +51.9% | +53.2% |
| EPS (Basic) | -$0.01 | +50.0% | +50.0% |
| EPS (Diluted) | -$0.01 | +50.0% | +50.0% |
| $46.6M |
| -14.0% |
| -35.8% |